RECRUITMENT
IGNITION Doctoral Network (DN) offers 13 PhD positions fully funded by the European Union’s Marie Sklodowska-Curie Actions (MSCA). This MSCA-DN action is distributed across 10 host institutions in 8 different European countries (Spain, Portugal, France, Italy, Germany, The Netherlands, Austria, Poland).
AIM
To advance knowledge in neuroimmunology and neurodegeneration having as a model anti-IgLON5 disease, a human disease where both disciplines are intertwined.
We are a European consortium ready to train the new generation of young resilient and passionate researchers, equipping them to become experts and future leaders in the fields of neuroimmunology and neurodegenerative diseases.
Our doctoral programme brings together complementary expertise in neurology, neuropathology, neuro-immunobiology, fluid biomarkers, OMICs, basic science, and animal models of autoimmune disorders. Doctoral Candidates (DCs) will be enrolled in the study of one, or more than one, scientific question.
WHAT do we offer?
Our multidisciplinary doctoral programme integrates cutting-edge techniques, leading academic expertise, entrepreneurship, and patient organizations to address critical challenges in understanding, diagnosing, and treating neuroimmunological and neurodegenerative diseases.
Each selected DC will receive a 36-month PhD employment contract to fulfil an Individual Research Project, which includes an international secondment.
All DCs will join a research group and benefit from high-level supervision throughout the project’s implementation. In addition, they will have access to a wide range of training and career development opportunities of their choice, such as the participation in IGNITION’s own Network Schools
The project culminates when the PhD thesis is defended.
WHO can apply?
Candidates from any nationality are welcomed to apply, but all applicants MUST meet the following criteria:
Academic background
Not hold a doctoral degree.
Doctoral program
Be eligible to enrol in a university doctoral program in the European Higher Education Area.
Mobility rule
Applicants must not have resided or carried out the main activity in the country of the recruiting beneficiary for more than 12 months in the 36 months prior the recruitment deadline.
Have a good English level
You can refer to the Guide for Applicants or contact us for any doubts.
You can refer to the Guide for Applicants or contact us
for any doubts at IGNITION@recerca.clinic.cat
HOW to apply?
If you comply with all the eligibility criteria, you can complete the online
application form. Recommendations BEFORE fulfilling the form:

STEP 1
We recommend you downloading and checking out the Form Template available in advance, so you can better prepare your answers. Bear in mind that there are several steps and it takes time to complete.

STEP 2
We recommend checking the Guide for Applicants and other documents that may be relevant in the end of this website.

STEP 3
We recommend examining the Individual Research Projects before starting the online application form, as you can select only three different Individual research project (IRP) priorities (check below). Please consider that you must be eligible in terms of mobility for each of the hosting labs leading the chosen IRPs.
VIEW AND CHECK DOCUMENTS
Once the online application form has been finished, an automatic Pdf file will be generated and sent to your e-mail address. To finalize the application, you must send this document to IGNITION’S Project Management IGNITION@recerca.clinic.cat along with the academic records.
Please check the Guide for Applicants for more information.
HOW is the evaluation process?
IGNITION partners will guarantee that the selection process complies with the Open, Transparent, and Merit-Based Recruitment (OTM-R) guidelines, as well as the MSCA Guidelines for Inclusion of Researchers at Risk, and the Code of Conduct for the Recruitment of Researchers (CCRR).
- 1
Once the candidate is confirmed to meet the eligibility criteria, which is mandatory to comply, the application will be sent to a gender-diverse Selection Panel, composed of two supervisors and another relevant member of the individual research project.
- 2
First step: background evaluation – the Selection Panel will assess the following features and provide merit points for each one.
- 3
Second step: online oral interviews – all candidates that obtain a minimum score will proceed to the interview with the Selection Panel.
- 4
A standardized evaluation will aid the Selection Panel to reach a final decision. Note that those candidates that were not chosen will form a “reserve list”. Selected candidates will have 1 week to accept or reject the formal offer.
Individual Research Projects
DC1
Advancements in clinical understanding and treatment of anti-IgLON5 disease.
(IDIBAPS)
DC2
Understanding contributions of adaptive and innate immunity in neurodegeneration.
(EMC)
DC3
Multiparametric analysis of biomarkers of neuroinflammation and neurodegeneration in anti-IgLON5 disease and other tauopathies.
(UKSH)
DC4
From Lab to Market: Developing diagnostic kits for antibodies against cell surface antigens and leveraging new biomarkers in neurodegenerative diseases.
(Biosystems)
DC5
Dissection of cell-intrinsic and cell-nonautonomous anti-IgLON5 disease mechanisms in vitro.
(HT)
DC6
Neuropathological studies on anti-IgLON5 disease human brains and other neurodegenerative diseases
(MUV)
DC7
The mechanisms of tau pathological spreading in anti-IgLON5 disease.
(UC)
DC8
Connecting scRNAseq to CyTOF single cell proteomics in anti-IgLON5 disease. Involvement of lysosomal cathepsins and legumain in tau cleavage using iPSC-derived neurons treated with anti-IgLON5 antibodies.
(PWR)
DC9
Anti-IgLON5 disease animal model: Passive transfer of anti-IgLON5 antibodies in a humanized MAPT knock-in mouse.
(UC)
DC10
Anti-IgLON5 encephalopathy induced in mice by active immunization and therapeutic approaches.
(IDIBAPS)
DC11
Study of the prognostic value of IgLON5-ab subclasses and pathogenic effect on muscle cells.
(MUV)
DC12
Crosstalk between IgLON5, binding partners and synapse in health and disease.
(CNRS)
DC13
In vivo mechanisms of IgLON5 antibodies on learning and memory consolidation.
(UKJ)
TRAINING PROGRAM
IGNITION is a training program designed to foster the next generation of neuro-immunologist leaders empowered to explore ground-breaking ideas and fuel innovation to solve urgent challenges in the field.
The training program is based on the Principles of Innovative Doctoral Training
Providing research excellence, attractive institutional environments, interdisciplinary and inter-sectoral elements to enhance future career opportunities, international networking, and quality and sustainability measures to maximize impact.
Doctoral Candidates will receive technical training and supervision in performing their cutting-edge, high-quality and original individual research projects at the leading host institutions and industrial partners.

Our advanced programme is structured in Modules:


